These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1067 related articles for article (PubMed ID: 30332562)

  • 1. Pathophysiology of Sickle Cell Disease.
    Sundd P; Gladwin MT; Novelli EM
    Annu Rev Pathol; 2019 Jan; 14():263-292. PubMed ID: 30332562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease.
    Nader E; Romana M; Connes P
    Front Immunol; 2020; 11():454. PubMed ID: 32231672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.
    Belcher JD; Chen C; Nguyen J; Milbauer L; Abdulla F; Alayash AI; Smith A; Nath KA; Hebbel RP; Vercellotti GM
    Blood; 2014 Jan; 123(3):377-90. PubMed ID: 24277079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sickle cell disease, vasculopathy, and therapeutics.
    Kassim AA; DeBaun MR
    Annu Rev Med; 2013; 64():451-66. PubMed ID: 23190149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of blood rheology in sickle cell disease.
    Connes P; Alexy T; Detterich J; Romana M; Hardy-Dessources MD; Ballas SK
    Blood Rev; 2016 Mar; 30(2):111-8. PubMed ID: 26341565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion.
    Conran N; Franco-Penteado CF; Costa FF
    Hemoglobin; 2009; 33(1):1-16. PubMed ID: 19205968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting novel mechanisms of pain in sickle cell disease.
    Tran H; Gupta M; Gupta K
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):546-555. PubMed ID: 29222304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting novel mechanisms of pain in sickle cell disease.
    Tran H; Gupta M; Gupta K
    Blood; 2017 Nov; 130(22):2377-2385. PubMed ID: 29187376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sickle cell disease: current treatment and emerging therapies.
    Neumayr LD; Hoppe CC; Brown C
    Am J Manag Care; 2019 Nov; 25(18 Suppl):S335-S343. PubMed ID: 31809007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboinflammatory mechanisms in sickle cell disease - challenging the hemostatic balance.
    Conran N; De Paula EV
    Haematologica; 2020 Oct; 105(10):2380-2390. PubMed ID: 33054078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease.
    Belcher JD; Nguyen J; Chen C; Abdulla F; Conglin R; Ivy ZK; Cummings J; Dudler T; Vercellotti GM
    Transl Res; 2022 Nov; 249():1-12. PubMed ID: 35878790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle cell disease vasculopathy: a state of nitric oxide resistance.
    Wood KC; Hsu LL; Gladwin MT
    Free Radic Biol Med; 2008 Apr; 44(8):1506-28. PubMed ID: 18261470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of vasculopathy in sickle cell disease and thalassemia.
    Morris CR
    Hematology Am Soc Hematol Educ Program; 2008; ():177-85. PubMed ID: 19074078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management.
    Nur E; Biemond BJ; Otten HM; Brandjes DP; Schnog JJ;
    Am J Hematol; 2011 Jun; 86(6):484-9. PubMed ID: 21544855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravascular hemolysis and the pathophysiology of sickle cell disease.
    Kato GJ; Steinberg MH; Gladwin MT
    J Clin Invest; 2017 Mar; 127(3):750-760. PubMed ID: 28248201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular pathophysiology of sickle cell disease.
    Connes P; Renoux C; Joly P; Nader E
    Presse Med; 2023 Dec; 52(4):104202. PubMed ID: 37944640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemia-Reperfusion Injury in Sickle Cell Disease: From Basics to Therapeutics.
    Ansari J; Gavins FNE
    Am J Pathol; 2019 Apr; 189(4):706-718. PubMed ID: 30904156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasculopathy and pulmonary hypertension in sickle cell disease.
    Potoka KP; Gladwin MT
    Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L314-24. PubMed ID: 25398989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Sickle Cell Disease Therapies: Targeting Pathways Downstream of Sickling.
    Morrone K; Mitchell WB; Manwani D
    Semin Hematol; 2018 Apr; 55(2):68-75. PubMed ID: 30616808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of oxidative stress in the pathogenesis of sickle cell disease.
    Chirico EN; Pialoux V
    IUBMB Life; 2012 Jan; 64(1):72-80. PubMed ID: 22131167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.